New York, NY, United States of America

Mary John


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mary John - Innovator in Cancer Treatment

Introduction

Mary John is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment, particularly through her innovative patents. With a total of 2 patents, her work focuses on utilizing humanized antibodies for therapeutic purposes.

Latest Patents

Mary John's latest patents include a method for treating neoplasia using humanized antibodies that bind to antigen A33. This invention involves the therapeutic use of these antibodies, which are crucial in treating various neoplasias, including colon cancer. The patent describes various modes of administration and dosing strategies. Another notable patent relates to methods of treating colon cancer utilizing tumor-specific antibodies. This invention focuses on reducing the effects of colon cancer tumors by conjugating various agents to monoclonal antibodies specific for colon cancer cells. These conjugates are administered to patients, effectively reducing the impact of the cancer.

Career Highlights

Throughout her career, Mary John has worked with esteemed organizations, including the Ludwig Institute for Cancer Research Limited. Her work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Mary has collaborated with notable professionals in her field, including Sydney Welt and Gerd J Ritter. These collaborations have further enriched her research and innovations.

Conclusion

Mary John's contributions to cancer treatment through her innovative patents highlight her dedication to improving healthcare. Her work continues to inspire advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…